Arvinas (ARVN) Operating Expenses (2017 - 2026)

Arvinas (ARVN) recorded quarterly Operating Expenses of $79.4 million in Q1 2026, down 5.59% quarter-over-quarter from $84.1 million in Q4 2025, and down 32.37% on a YoY basis from $117.4 million in Q1 2025.

Arvinas (ARVN) Operating Expenses (2017 - 2026) Analysis & Trends

Arvinas' Operating Expenses history runs 10 years deep, the most recent figure standing at $79.4 million for Q1 2026.

  • In Q1 2026, Operating Expenses fell 32.37% year-over-year to $79.4 million; the TTM figure through Mar 2026 stood at $343.1 million (down 34.33% YoY), while the FY2025 annual figure was $381.1 million, down 25.8% from the prior year.
  • Operating Expenses was $79.4 million for Q1 2026 at Arvinas, down from $84.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $162.7 million in Q3 2024 to a low of $79.4 million in Q1 2026.
  • Historically, Operating Expenses has averaged $108.8 million across 5 years, with a median of $108.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 78.39% in 2022, then tumbled 47.33% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $113.4 million in 2022, then grew by 7.76% to $122.2 million in 2023, then decreased by 3.93% to $117.4 million in 2024, then dropped by 28.36% to $84.1 million in 2025, then decreased by 5.59% to $79.4 million in 2026.
  • The last three Operating Expenses figures came in at $79.4 million (Q1 2026), $84.1 million (Q4 2025), and $85.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.33 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -138.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 574,669.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.85 Bn
9 Abivax 91.96 Bn 91.96 Bn - -67.40 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 79.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 79.40 Mn
Dec 31, 2025 84.10 Mn
Sep 30, 2025 85.70 Mn
Jun 30, 2025 93.90 Mn
Mar 31, 2025 117.40 Mn
Dec 31, 2024 117.40 Mn
Sep 30, 2024 162.70 Mn
Jun 30, 2024 125.00 Mn
Mar 31, 2024 108.60 Mn
Dec 31, 2023 122.20 Mn
Sep 30, 2023 108.50 Mn
Jun 30, 2023 129.10 Mn
Mar 31, 2023 120.20 Mn
Dec 31, 2022 113.40 Mn
Sep 30, 2022 97.50 Mn
Jun 30, 2022 99.60 Mn
Mar 31, 2022 84.20 Mn
Dec 31, 2021 80.70 Mn
Sep 30, 2021 56.60 Mn
Jun 30, 2021 57.40 Mn